| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risk factors for HIV infection among men who have sex with men.
|
AIDS
|
2006
|
7.01
|
|
2
|
High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study.
|
Am J Public Health
|
2003
|
4.67
|
|
3
|
Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men.
|
Am J Epidemiol
|
2004
|
4.03
|
|
4
|
An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study.
|
Am J Public Health
|
2003
|
2.72
|
|
5
|
Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion.
|
AIDS
|
2002
|
2.33
|
|
6
|
The increase in global HIV epidemics in MSM.
|
AIDS
|
2013
|
1.88
|
|
7
|
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.
|
J Acquir Immune Defic Syndr
|
2005
|
1.87
|
|
8
|
Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.
|
PLoS One
|
2011
|
1.84
|
|
9
|
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
|
PLoS One
|
2010
|
1.73
|
|
10
|
Effect of same-sex marriage laws on health care use and expenditures in sexual minority men: a quasi-natural experiment.
|
Am J Public Health
|
2011
|
1.72
|
|
11
|
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.
|
J Acquir Immune Defic Syndr
|
2013
|
1.50
|
|
12
|
The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries.
|
Sex Transm Dis
|
2011
|
1.50
|
|
13
|
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.
|
AIDS Behav
|
2015
|
1.49
|
|
14
|
Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.
|
Immunology
|
2009
|
1.37
|
|
15
|
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
|
Clin Infect Dis
|
2013
|
1.31
|
|
16
|
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
|
J Infect Dis
|
2003
|
1.28
|
|
17
|
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women.
|
J Infect Dis
|
2003
|
1.27
|
|
18
|
Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V.
|
AIDS Behav
|
2009
|
1.26
|
|
19
|
Genital tract leukocytes and shedding of genital HIV type 1 RNA.
|
Clin Infect Dis
|
2008
|
1.25
|
|
20
|
Design of a stage-matched intervention trial to increase dual method contraceptive use (Project PROTECT).
|
Contemp Clin Trials
|
2007
|
1.21
|
|
21
|
Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
|
AIDS Care
|
2007
|
1.20
|
|
22
|
Impact of age on retention in care and viral suppression.
|
J Acquir Immune Defic Syndr
|
2015
|
1.17
|
|
23
|
HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum.
|
J Infect Dis
|
2011
|
1.15
|
|
24
|
Geography should not be destiny: focusing HIV/AIDS implementation research and programs on microepidemics in US neighborhoods.
|
Am J Public Health
|
2014
|
1.13
|
|
25
|
Women's experiences with anal sex: motivations and implications for STD prevention.
|
Perspect Sex Reprod Health
|
2009
|
1.12
|
|
26
|
HIV rates and risk behaviors are low in the general population of men in Southern India but high in alcohol venues: results from 2 probability surveys.
|
J Acquir Immune Defic Syndr
|
2007
|
1.09
|
|
27
|
Persistence of inconsistent condom use: relation to abuse history and HIV serostatus.
|
AIDS Behav
|
2004
|
1.07
|
|
28
|
Knowledge, attitudes, and practices among physicians on HIV/AIDS in Quang Ninh, Vietnam.
|
AIDS Patient Care STDS
|
2005
|
1.07
|
|
29
|
Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men.
|
Sex Transm Dis
|
2010
|
1.06
|
|
30
|
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
|
Clin Infect Dis
|
2006
|
1.01
|
|
31
|
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.
|
J Acquir Immune Defic Syndr
|
2014
|
1.00
|
|
32
|
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
|
Clin Infect Dis
|
2014
|
1.00
|
|
33
|
Clinician practices and attitudes regarding early antiretroviral therapy in the United States.
|
J Acquir Immune Defic Syndr
|
2012
|
0.99
|
|
34
|
HIV and obstetric complications and fetal outcomes in Vellore, India.
|
Trop Doct
|
2008
|
0.99
|
|
35
|
Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial.
|
AIDS Behav
|
2010
|
0.99
|
|
36
|
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
|
Clin Infect Dis
|
2002
|
0.97
|
|
37
|
Sex position, marital status, and HIV risk among Indian men who have sex with men: clues to optimizing prevention approaches.
|
AIDS Patient Care STDS
|
2011
|
0.95
|
|
38
|
Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy.
|
J Infect Dis
|
2007
|
0.95
|
|
39
|
Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use.
|
Sex Transm Dis
|
2002
|
0.95
|
|
40
|
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.
|
J Acquir Immune Defic Syndr
|
2013
|
0.95
|
|
41
|
Social network and risk-taking behavior most associated with rapid HIV testing, circumcision, and preexposure prophylaxis acceptability among high-risk Indian men.
|
AIDS Patient Care STDS
|
2012
|
0.93
|
|
42
|
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.
|
Hum Immunol
|
2011
|
0.93
|
|
43
|
Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research.
|
AIDS Behav
|
2014
|
0.92
|
|
44
|
Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women.
|
J Med Microbiol
|
2011
|
0.92
|
|
45
|
Preparing for efficacy trials of vaginal microbicides in Indian women.
|
Indian J Med Res
|
2005
|
0.90
|
|
46
|
Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals.
|
AIDS Res Hum Retroviruses
|
2003
|
0.90
|
|
47
|
Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
|
J Virol
|
2009
|
0.88
|
|
48
|
Routine brief risk-reduction counseling with biannual STD testing reduces STD incidence among HIV-infected men who have sex with men in care.
|
Sex Transm Dis
|
2012
|
0.88
|
|
49
|
The development and utility of a clinical algorithm to predict early HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2005
|
0.87
|
|
50
|
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.
|
J Acquir Immune Defic Syndr
|
2017
|
0.87
|
|
51
|
Microflora changes with the use of a vaginal microbicide.
|
Sex Transm Dis
|
2002
|
0.86
|
|
52
|
Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.
|
AIDS Behav
|
2014
|
0.85
|
|
53
|
Comprehensive transgender healthcare: the gender affirming clinical and public health model of fenway health.
|
J Urban Health
|
2015
|
0.83
|
|
54
|
Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis.
|
Int J STD AIDS
|
2012
|
0.80
|
|
55
|
Willingness to receive an HIV vaccine among incarcerated persons.
|
Prev Med
|
2006
|
0.79
|
|
56
|
Identifying acute HIV infection in Rhode Island.
|
Med Health R I
|
2009
|
0.78
|
|
57
|
Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.
|
AIDS Behav
|
2015
|
0.78
|
|
58
|
Barriers and Facilitators of HIV Disclosure: Perspectives from HIV-Infected Men Who Have Sex with Men.
|
J HIV AIDS Soc Serv
|
2008
|
0.77
|
|
59
|
The effects of illicit drug use and HIV infection on sex hormone levels in women.
|
Gynecol Endocrinol
|
2006
|
0.77
|
|
60
|
The evolving Indian AIDS epidemic: hope & challenges of the fourth decade.
|
Indian J Med Res
|
2011
|
0.77
|
|
61
|
Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.
|
AIDS
|
2013
|
0.77
|
|
62
|
Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.
|
AIDS
|
2015
|
0.76
|
|
63
|
Editorial Commentary: a tale of 2 realities: what are the challenges and solutions to improving Engagement in HIV care?
|
Clin Infect Dis
|
2013
|
0.75
|
|
64
|
Sources of racial/ethnic differences in awareness of HIV vaccine trials.
|
Am J Public Health
|
2014
|
0.75
|
|
65
|
Building Program Acceptability: Perceptions of Gay and Bisexual Men on Peer or Prevention Case Manager Relationships in Secondary HIV Prevention Counseling.
|
J Gay Lesbian Soc Serv
|
2010
|
0.75
|
|
66
|
HIV vaccine update: recent developments and current trials.
|
Med Health R I
|
2007
|
0.75
|
|
67
|
Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.
|
AIDS
|
2017
|
0.75
|
|
68
|
2020, sexually transmissible infections and HIV in gay, bisexual and other men who have sex with men.
|
Sex Health
|
2017
|
0.75
|